+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Drugs By Therapeutic Area Market Research Reports

Rabies Infection - Pipeline Insight, 2025 - Product Thumbnail Image

Rabies Infection - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 50 Pages
  • Global
From
Chronic Rhinosinusitis - Pipeline Insight, 2025 - Product Thumbnail Image

Chronic Rhinosinusitis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 40 Pages
  • Global
From
Sturge-Weber Syndrome - Pipeline Insight, 2025 - Product Thumbnail Image

Sturge-Weber Syndrome - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 40 Pages
  • Global
From
Buerger's Disease - Pipeline Insight, 2025 - Product Thumbnail Image

Buerger's Disease - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 40 Pages
  • Global
From
Bronchiolitis Obliterans Syndrome - Pipeline Insight, 2025 - Product Thumbnail Image

Bronchiolitis Obliterans Syndrome - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Immunologic Deficiency Syndrome - Pipeline Insight, 2025 - Product Thumbnail Image

Immunologic Deficiency Syndrome - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Endocarditis - Pipeline Insight, 2025 - Product Thumbnail Image

Endocarditis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 40 Pages
  • Global
From
Kidney Transplant Rejection - Pipeline Insight, 2025 - Product Thumbnail Image

Kidney Transplant Rejection - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Opioid Related Disorder - Pipeline Insight, 2025 - Product Thumbnail Image

Opioid Related Disorder - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 50 Pages
  • Global
From
Macular Telangiectasia (MacTel) - Pipeline Insight, 2025 - Product Thumbnail Image

Macular Telangiectasia (MacTel) - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Anaphylaxis - Pipeline Insight, 2025 - Product Thumbnail Image

Anaphylaxis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 40 Pages
  • Global
From
Behçet Disease - Pipeline Insight, 2025 - Product Thumbnail Image

Behçet Disease - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Trigeminal Neuralgia- Pipeline Insight, 2025 - Product Thumbnail Image

Trigeminal Neuralgia- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Hypovolemia - Pipeline Insight, 2025 - Product Thumbnail Image

Hypovolemia - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 50 Pages
  • Global
From
Schizoaffective Disorder - Pipeline Insight, 2025 - Product Thumbnail Image

Schizoaffective Disorder - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Adult Growth Hormone Deficiency (AGHD) - Pipeline Insight, 2025 - Product Thumbnail Image

Adult Growth Hormone Deficiency (AGHD) - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Proliferative Vitreoretinopathy - Pipeline Insight, 2025 - Product Thumbnail Image

Proliferative Vitreoretinopathy - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 40 Pages
  • Global
From
Excessive Daytime Sleepiness - Pipeline Insight, 2025 - Product Thumbnail Image

Excessive Daytime Sleepiness - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Crohn's Disease - Pipeline Insight, 2025 - Product Thumbnail Image

Crohn's Disease - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 240 Pages
  • Global
From
Small Fiber Neuropathy - Pipeline Insight, 2025 - Product Thumbnail Image

Small Fiber Neuropathy - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 40 Pages
  • Global
From
Loading Indicator

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more